Asymmetric Audiovestibular Dysfunction in Patients With Systemic Aminoglycoside Treatment
- Author:
Jae Hong PARK
1
;
Yoon Chan RAH
;
Ji Soo KIM
;
Ja Won KOO
Author Information
1. Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. jwkoo99@snu.ac.kr
- Publication Type:Case Report
- Keywords:
Aminoglycosides;
Ototoxicity;
Vestibular schwannoma
- MeSH:
Aminoglycosides;
Hearing Loss, Sensorineural;
Humans;
Neuroma, Acoustic
- From:Journal of the Korean Balance Society
2013;12(2):62-66
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Since the characteristics of aminoglycoside ototoxicity is typically bilaterally symmetric progression of cochlea-vestibular dysfunction, a unilateral involvement has rarely been reported. However, ototoxicity can be asymmetric or focal after systemic aminoglycoside treatment. The authors report 2 cases of asymmetric or focal audiovestibular deficits in patients treated with systemic aminoglycoside. In such cases, further investigations are also necessary to rule out other possible causes of unilateral sensorineural hearing loss such as cerebellopontine angle tumors.
